Risk factors for type-1 reactions in borderline leprosy patients
- 1 September 1991
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 338 (8768) , 654-657
- https://doi.org/10.1016/0140-6736(91)91232-j
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The Response to Chemotherapy of Serum Mycobacterium Leprae-Specific Antigen in Multibacillary Leprosy PatientsThe American Journal of Tropical Medicine and Hygiene, 1991
- Serological responses in primary neuritic leprosyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- Correlation of bacterial viability with uptake of [14C] acetate into phenolic glycolipid-1 ofMycobacterium leprae within Schwannoma cellsJournal of Biosciences, 1989
- Axenic incorporation of [U-14C]palmitic acid into the phenolic glycolipid-I ofMycobacterium lepraeFEMS Microbiology Letters, 1987
- Mycobacterial Carbohydrate Antigens for Serological Testing of Patients with LeprosyThe Journal of Infectious Diseases, 1987
- Leprosy and the Leprosy Bacillus: Recent Developments in Characterization of Antigens and Immunology of the DiseaseAnnual Review of Microbiology, 1987
- Phenolic glycolipid 1 of Mycobacterium leprae causes nonspecific inflammation but has no effect on cell-mediated responses in miceInfection and Immunity, 1984
- A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicityJournal of Bacteriology, 1981